PHARMACOKINETICS OF TOTAL AND FREE VALPROIC ACID DURING MONOTHERAPY IN INFANTS

被引:13
|
作者
HERNGREN, L [1 ]
LUNDBERG, B [1 ]
NERGARDH, A [1 ]
机构
[1] KAROLINSKA HOSP,DEPT PAEDIAT,S-10401 STOCKHOLM 60,SWEDEN
关键词
VALPROIC ACID; INFANTS; PROTEIN BINDING; PHARMACOKINETICS;
D O I
10.1007/BF00315328
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pharmacokinetics of free and total valproic acid (VPA) in plasma and whole blood after oral administration during steady state was investigated in seven infants (mean age 10.7 months) receiving monotherapy. The VPA concentrations in whole blood closely followed those in plasma but at a reduced level. A positive correlation was found between dose and mean plasma concentration (r = 0.71). Mean terminal half-lives were similar in plasma and whole blood (12.5 and 15.5 h, respectively), but were considerably longer than for free VPA (6.4 and 6.5 h, respectively; P < 0.01). There was a significant decrease in half-lives with increasing age (P < 0.05). Plasma and whole blood clearance for total VPA was higher than reported in older infants and adults (17.8 and 28.9 ml/kg per hour) and was considerably higher for free VPA (127.6 and 188.8 ml/kg per hour, respectively). The increase in clearance compared with that in older subjects is well in concordance with a lower protein binding of VPA (mean 85.3%). Of special importance is that the percentage of unbound VPA increased with increasing concentrations of total VPA. The fraction of unbound VPA in plasma increased even more in subjects with low albumin concentrations (P < 0.01).
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [31] Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients
    Shakir, Shakirullah
    Ali, Niaz
    Nazish, Haleema
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (05): : 357 - 360
  • [32] Valproic acid monotherapy induces DNA oxidative damage
    Schulpis, KH
    Lazaropoulou, C
    Regoutas, S
    Karikas, GA
    Margeli, A
    Tsakiris, S
    Papassotiriou, I
    TOXICOLOGY, 2006, 217 (2-3) : 228 - 232
  • [33] Salivary levels of valproic acid in children with antiepileptic monotherapy
    Fagiolino, Pietro
    Vazquez, Marta
    Olano, Ivette
    Maldonado, Cecilia
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 535 - 535
  • [34] Simple and rapid GC procedure for quantitation of total and free Valproic Acid.
    Bigdeli, MG
    Falahat-Pisheh, HR
    Javadi-Nejad, F
    CLINICAL CHEMISTRY, 2002, 48 (06) : A40 - A40
  • [35] EFFECT OF DIFFERENT DOSES OF VALPROIC ACID ON THE SERUM LEVELS OF TOTAL AND FREE DIPHENYLHYDANTOIN
    ALVAREZ, N
    CLINICAL ELECTROENCEPHALOGRAPHY, 1985, 16 (02): : 104 - 110
  • [36] PHARMACOKINETICS OF ENTERIC-COATED VALPROIC ACID
    ALBRIGHT, PS
    BRUNI, J
    SURIA, D
    THERAPEUTIC DRUG MONITORING, 1984, 6 (01) : 21 - 23
  • [37] Pharmacokinetics of valproic acid in patients with bipolar disorder
    Vasudev, K
    Das, S
    Goswami, U
    Tayal, G
    JOURNAL OF PSYCHOPHARMACOLOGY, 2001, 15 (03) : 187 - 190
  • [38] Effects of Carnitine on Valproic Acid Pharmacokinetics in Rats
    Katayama, Hirokazu
    Mizukami, Kohki
    Yasuda, Manami
    Hatae, Tomomi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (10) : 3199 - 3204
  • [39] PHYSIOLOGICALLY BASED PHARMACOKINETICS OF VALPROIC ACID IN RABBITS
    ICHIMURA, F
    DEGUCHI, Y
    YOKOGAWA, K
    YAMANA, T
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (01) : 45 - 60
  • [40] PHARMACOKINETICS OF VALPROIC ACID IN YOUNG AND ELDERLY SUBJECTS
    BRYSON, SM
    VERMA, N
    SCOTT, PJW
    RUBIN, PC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (01) : 104 - 105